Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for Lu-PSMA Efficacy in mCRPC (PSMA-PRED)
NCT06600802Recruiting
- Sponsor
- Centre Jean Perrin
- Start
- Oct 2024
- Primary completion
- Jun 2034
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Centre Jean Perrin. Primary endpoint: Molecular abnormalities retained on primary tumor sample predicting response to Lu-PSMA at 24 months. Started Oct 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06600802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06600802.